Potent Ack1 and anaplastic lymphoma kinase (ALK) dual inhibitor (IC50
values are 4 and 12 nM respectively). Inhibits lung cancer H3122 cell proliferation (IC50
= 80 nM). Attenuates H3122 cell xenograft tumor growth in mice. Orally bioavailable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment.
Park et al.
ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatment.
Lee et al.